[BrokerRatings]Wall Street Analyst Ratings: Tech and Medical Devices Lead Mid-November Momentum

This update was written automatically with AI from market data and news wire reports, and published without review by a person.

Medical Devices lead the charge with 3 stocks (ZBH, IDXX, MNPR) recently rated strong buy or upgraded by analysts this Tuesday. Tech giants also show resilience as NVDA maintains a $221 average target despite leadership shifts, while DIS gains favor following dividend hikes. Momentum is supported by a 15% average target upside in semiconductors like MU. However, new AI export curbs signal caution for growth-heavy portfolios.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top